VOYAGEUR PHARMACEUTICALS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.055 CAD | +10.00% |
|
+10.00% | -26.67% |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 5.31M 7.3M 425M |
|---|---|---|---|---|---|
| Net income 2022 | -1M -1.38M -80.06M | Net income 2023 | -1M -1.38M -80.06M | EV / Sales 2022 | - |
| Net cash position 2022 | 11.99K 16.5K 960K | Net Debt 2023 | 34.42K 47.36K 2.76M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-4.3
x | P/E ratio 2023 |
-3.73
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.79% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +10.00% | ||
| 1 week | +10.00% | ||
| Current month | -21.43% | ||
| 1 month | -15.38% | ||
| 3 months | -31.25% | ||
| 6 months | +22.22% | ||
| Current year | -26.67% |
1 week
0.05
0.06
1 month
0.040.07
Current year
0.040.09
1 year
0.040.09
3 years
0.040.20
5 years
0.040.35
10 years
0.040.35
| Managers | Title | Age | Since |
|---|---|---|---|
Brent Willis
FOU | Founder | - | 05/12/17 |
| Director of Finance/CFO | - | 16/08/22 | |
Brad Willis
COO | Chief Operating Officer | - | 01/03/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ronald L. Sifton
BRD | Director/Board Member | 71 | 19/01/20 |
Ralph Hesje
BRD | Director/Board Member | - | 25/07/21 |
Brent Willis
FOU | Founder | - | 05/12/17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 0.055 | +10.00% | 14,155 |
| 29/04/24 | 0.05 | -.--% | 74,500 |
| 26/04/24 | 0.05 | -.--% | 63,500 |
| 25/04/24 | 0.05 | -9.09% | 10,000 |
Delayed Quote Toronto S.E., April 30, 2024 at 02:30 pm
More quotes
Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.
Sector
Pharmaceuticals
Calendar
29/07/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -26.67% | 5.56M | |
| +34.00% | 704B | |
| +27.37% | 577B | |
| -7.75% | 348B | |
| +18.53% | 327B | |
| +4.95% | 288B | |
| +14.77% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.89% | 147B |
- Stock Market
- Equities
- VM Stock
